Secretsos Small Business Grant

The Wisconsin Economic Development Corporation is partnering to offer Entrepreneurial Training Program reimbursement of up to 75% of the $1,000 course fee. The course is designed to help early-stage startups vet their ideas and learn how to develop an investment-ready business plan. Grant recipients must comply with requirements that include meeting attendance standards and completing a business plan within six months of starting the program.

This FOA encourages research relevant to the development of novel screening approaches and/or therapeutic interventions for potentially fatal or disabling conditions that have been identified through newborn screening, as well as for "high priority" genetic conditions where screening may be possible in the near future.Having an accurate screening test, as well as demonstrating the benefits of early intervention or treatment, are important criteria for including a condition on a newborn screening panel. This FOA defines a "high priority" condition as one where screening is not currently recommended, but infants with the condition would significantly benefit from early identification and treatment.

The Backing Small Businesses grant program, supported by American Express, provides support to locally significant small businesses with community reach. The program provides grants of $10,000 to fund projects that promote sustainable growth, enhance long-term resilience, and increase local impact.

She's Connected by AT&T is open to U.S.-based small-businesses that are women-owned and have fewer than 51 employees. The grand prize winner will receive a $50,000 grant and a year of free AT&T service alongside a new device. Four runner-up businesses will receive $5,000 microgrants.

This Notice of Funding Opportunity (NOFO) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Project (R01) grant applications from institutions or organizations that propose to develop or support the development of designated new animal drugs intended for minor uses in major species or for use in minor species (MUMS). The FDA is authorized to provide grants to assist in defraying the costs of qualified safety and effectiveness testing that could be used to satisfy the requirements for FDA approval of MUMS-designated drugs. Only entities developing drugs for veterinary use or parties working as research partners with such entities are eligible for grants. The organization (or applicant) seeking approval of the new animal drug under investigation must have opened an Investigational New Animal Drug (INAD) file with FDA/CVM and must hold a minor use or minor species "designation" granted by FDA/CVM's Office of Minor Use and Minor Species Animal Drug Development (OMUMS) for that drug for a specified intended use, in accordance with the provisions of section 573 of the Food, Drug and Cosmetic Act (21 U.S.C. 360ccc-2) and 21 CFR part 516.